Published in

Royal Society of Chemistry, MedChemComm, 12(10), p. 2078-2088, 2019

DOI: 10.1039/c9md00336c

Links

Tools

Export citation

Search in Google Scholar

Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists

Journal article published in 2019 by Margherita Mastromarino, Liliya N. Kirpotina, Igor A. Schepetkin, Mark T. Quinn ORCID, Enza Lacivita ORCID, Marcello Leopoldo ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Aurantiamide is a useful scaffold to develop promising FPR1 antagonists capable of inhibiting neutrophil chemotaxis.